Role of the DEK oncogene in the development of squamous cell carcinoma Kazuhisa IshidaTakayuki NakashimaHiroyuki Tomita Review Article Open access 12 July 2020 Pages: 1563 - 1569
Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review Dimitrios K . ManatakisNikolaos GouvasEvangelos Xynos Review Article 14 July 2020 Pages: 1570 - 1580
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic Mozaffar Aznab Original Article 11 July 2020 Pages: 1581 - 1586
Association between chronic kidney disease and mortality in stage IV cancer Taisuke IshiiTakuya FujimaruYasuhiro Komatsu Original Article 08 June 2020 Pages: 1587 - 1595
Chemoradiotherapy for high-risk stage II laryngeal cancer Satoshi HamauchiTomoya YokotaHirofumi Yasui Original Article 22 May 2020 Pages: 1596 - 1603
Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining Yusuke IkedaTaiki SuzukiTakeshi Nomura Original Article Open access 25 May 2020 Pages: 1604 - 1611
FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma Fengrui ZhouXin WangYan Yu Original Article 19 May 2020 Pages: 1612 - 1623
The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis Ke XuTao LiuTao Ren Original Article 29 May 2020 Pages: 1624 - 1634
Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials Hisato KawakamiKazumasa Fujitanifor the Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) Original Article 03 June 2020 Pages: 1635 - 1643
Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort Stefano SignoroniGuglielmo Niccolò PiozziMarco Vitellaro Original Article 19 May 2020 Pages: 1644 - 1652
Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer Xue ChaoZixian WangJingping Yun Original Article 16 June 2020 Pages: 1653 - 1662
Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance Mayumi Kobayashi KatoDai ShidaTomoyasu Kato Original Article 03 June 2020 Pages: 1663 - 1671
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients Warit RuanglertboonMichael J. SorichAshley M. Hopkins Original Article 16 May 2020 Pages: 1672 - 1677
Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab Kotaro SuzukiTomoaki TerakawaMasato Fujisawa Original Article 02 June 2020 Pages: 1678 - 1686
Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan Tomokazu KimuraKoji KawaiHiroyuki Nishiyama Original Article 25 May 2020 Pages: 1687 - 1694
Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer Wataru FukuokayaTakahiro KimuraShin Egawa Original Article 02 June 2020 Pages: 1695 - 1703
Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy Takeshi HashimotoJun NakashimaYoshio Ohno Original Article 04 June 2020 Pages: 1704 - 1710
Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy Tomoki TaniguchiKoji IinumaTakuya Koie Original Article 05 June 2020 Pages: 1711 - 1717
Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy Kyoko ShimadaShoji NagaoSatoshi Yamaguchi Original Article 23 May 2020 Pages: 1718 - 1725
Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence Shinichi TateKyoko NishikimiMakio Shozu Original Article 04 June 2020 Pages: 1726 - 1735
Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma Hideki GotoShinichi MakitaTakanori Teshima Original Article Open access 24 May 2020 Pages: 1736 - 1743
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) Tomoro HishikiKimikazu MatsumotoFor the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) Correction 04 August 2020 Pages: 1744 - 1745